All In MedTech

Device Trial Radar · NCT04663867

AngioSafe Peripheral CTO Crossing System Study (RESTOR-1 Study)

Safety and Effectiveness Study of the AngioSafe Peripheral CTO Crossing System

Last checked: Nov 20, 2026Latest source record: Feb 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

79

Actual

Start

Feb 3, 2021

Primary completion

Apr 25, 2023

Study completion Jun 15, 2023

Sponsor

Lead sponsor
AngioSafe, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Veranex, Inc.
First posted
Dec 11, 2020

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The study is designed to evaluate the safety and efficacy of the AngioSafe Peripheral CTO Crossing System.

Conditions

  • Peripheral Artery Occlusion
  • Peripheral Arterial Disease

Interventions

  • AngioSafe Peripheral CTO Crossing SystemDevice

    The AngioSafe Peripheral CTO Crossing System is intended to facilitate the intraluminal placement of guidewires beyond stenotic lesions, including chronic total occlusions (CTOs) in the peripheral vasculature.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Clinical Success of AngioSafe Peripheral CTO Crossing SystemTime frame: 24 Hours

Locations

18 sites in 1 country. Site status is shown where the registry gives one.

  • Dignity Health - Chandler Regional Medical Center

    Chandler, Arizona

  • Adventist Health St. Helena

    St. Helena, California

  • Vascular Care Connecticut

    Darien, Connecticut

15 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.